Category: Research & Clinical Trials

Dr. Robert Cameron will discuss advances in cancer treatment at the 2014 International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma.

The 11th annual International Symposium on Mesothelioma will take place in Alexandria, Virginia with specialists discussing the latest news and discoveries.

Researchers have found that fibrinogen levels within mesothelioma patients may help doctors find patients’ survival rate and if surgery adds any value.

Moffitt Cancer Center researchers discover that mesothelioma patients could live longer lives with a second round of cytoreductive surgery and HIPEC.

The future of cancer staging and treatment of pleural mesothelioma patients can be improved by looking closely at particular lymph nodes.

Researchers at the National Cancer Institute discover a way to reduce mesothelioma tumors using SS1P immunotoxin in conjunction with two immune suppressors.

The international clinical trial, which is expected to involve 350-400 patients across 11 countries, will study the cancer stem cell inhibitor defactinib.

Animal rights advocates question funding of primate-based mesothelioma research, especially when new ethical treatments are being implemented.